InvestorsObserver
×
News Home

Will Brickell Biotech Inc (BBI) Beat the Rest of the Stocks in the Healthcare Sector?

Friday, April 22, 2022 01:52 PM | InvestorsObserver Analysts

Mentioned in this article

Will Brickell Biotech Inc (BBI) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 90 puts Brickell Biotech Inc (BBI) near the top of the Healthcare sector according to InvestorsObserver. Brickell Biotech Inc's score of 90 means that it ranks higher than 90% of stocks in the sector. In addition, its overall score of 46 ranks it higher than 46% of all stocks.

Overall Score - 46
BBI has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on BBI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 46 means the stock is more attractive than 46 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Brickell Biotech Inc Stock Today?

Brickell Biotech Inc (BBI) stock has risen 3.69% while the S&P 500 is lower by -1.98% as of 1:52 PM on Friday, Apr 22. BBI has risen $0.01 from the previous closing price of $0.31 on volume of 15,734,431 shares. Over the past year the S&P 500 is up 4.15% while BBI is lower by -64.04%. BBI lost -$0.49 per share the over the last 12 months. Click Here to get the full Stock Report for Brickell Biotech Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App